Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Medtronic
Express Scripts

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Poloxamer 188

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Poloxamer 188: Patents, clinical trial progress, indications

Poloxamer 188 is an investigational drug.

There have been 5 clinical trials for Poloxamer 188. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 1997.

The most common disease conditions in clinical trials are Anemia, Sickle Cell, Vascular Diseases, and Peripheral Vascular Diseases. The leading clinical trial sponsors are Mast Therapeutics, Inc., Asan Medical Center, and Valentis.

Recent Clinical Trials for Poloxamer 188
TitleSponsorPhase
Evaluation of Repeat Administration of Purified Poloxamer 188Mast Therapeutics, Inc.Phase 3
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)Mast Therapeutics, Inc.Phase 3
Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersAsan Medical CenterPhase 1

See all Poloxamer 188 clinical trials

Clinical Trial Summary for Poloxamer 188

Top disease conditions for Poloxamer 188
Top clinical trial sponsors for Poloxamer 188

See all Poloxamer 188 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
AstraZeneca
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.